✦ LIBER ✦

A Benefit-Risk Assessment of Sibutramine in the Management of Obesity

✍ Scribed by Dr Enzo Nisoli, Michele O. Carruba

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Risk-Benefit Assessment of Anti-Obesit

✍ Professor Jaroslaw Kolanowski 📂 Article 📅 1999 🏛 Springer International Publishing AG 🌐 English ⚖ 159 KB

Benefit-Risk Assessment of Antileukotrie

✍ Dr Luis García-Marcos, Antje Schuster, Eduardo G. Pérez-Yarza 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 253 KB

The benefits of assessing risk in PV pro

✍ Tucker, Reginald; Butler, Evelyn 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 723 KB

Benefit-Risk Assessment of Ropivacaine i

✍ Wolfgang Zink, Dr Bernhard M. Graf 📂 Article 📅 2004 🏛 Springer International Publishing AG 🌐 English ⚖ 178 KB

Assessment of clinical and economic bene

✍ Alan Brennan; Roberta Ara; Raimund Sterz; Bernd Matiba; Rito Bergemann 📂 Article 📅 2006 🏛 Springer 🌐 French ⚖ 780 KB

A Risk-Benefit Assessment of Epoetin in

✍ Dr Yves Beguin 📂 Article 📅 1998 🏛 Springer International Publishing AG 🌐 English ⚖ 161 KB